P746: COMBINATION OF RAS/MAPK MODULATOR AND AZACITIDINE AFFECTS HISTONE MARKS AND IMPACTS THE INNATE IMMUNE SIGNALING PATHWAY IN THE MDS-L CELL LINE

• R. Rai,
• F. Patel,
• J. Feld,
• S. Melana,
• S. Navada,
• R. Odchimar-Reissig,
• E. Demakos,
• E. P. Reddy,
• A. Horowitz,
• L. Silverman

Affiliations

R. Rai

1 Division of Hematology and Medical Oncology

F. Patel

1 Division of Hematology and Medical Oncology

J. Feld

1 Division of Hematology and Medical Oncology

S. Melana

1 Division of Hematology and Medical Oncology

S. Navada

1 Division of Hematology and Medical Oncology

R. Odchimar-Reissig

1 Division of Hematology and Medical Oncology

E. Demakos

1 Division of Hematology and Medical Oncology

E. P. Reddy

2 Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States of America

A. Horowitz

2 Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States of America

L. Silverman

1 Division of Hematology and Medical Oncology